ECL · Q4 2025 Earnings

Bullish

Ecolab

Reported February 10, 2026

30-second summary

Ecolab closed FY2025 exactly at the $7.53 EPS midpoint with Q4 adjusted EPS of $2.08 in the upper half of the $2.02–$2.12 guide (+15% YoY), and the high-tech "growth wave" finally got sized — ~$1B of revenue growing strong double digits, with the Ovivo Electronics acquisition already securing new fabs in early 2026. The forward setup is the actual news: FY2026 EPS guide of $8.43–$8.63 (+12–15%) at the formalized growth band, 100–150bps of operating margin expansion (implying ~18.9–19.3% from 17.9%), and the OneEcolab savings target raised for the second time in a year — from $225M to $325M by 2027, with ~$120M booked by end-2025 and the remaining $200M split evenly across 2026–2027. The 20%-OI-by-2027 path is now mechanically underwritten.

Headline numbers

EPS

Q4 FY2025

$2.08

Revenue

Q4 FY2025

$4.20B

+5.0% YoY

Gross margin

Q4 FY2025

44.1%

Operating margin

Q4 FY2025

18.5%

Key financials

Q4 FY2025

Metric	Q4 FY2025	YoY	Q3 FY2025	QoQ
Revenue	$4.20B	+5.0%	$4.17B	+0.7%
EPS	$2.08	—	$2.07	+0.5%
Gross margin	44.1%	—	44.8%	-70bps
Operating margin	18.5%	—	18.3%	+20bps

Guidance

Ecolab delivered FY2025 within guidance, narrowing Q4 EPS to the high end of the range; forward FY2026 guidance implies 12–15% EPS growth with 100–150 bps margin expansion, underpinned by 3–4% organic growth and modest volume recovery.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Adjusted Diluted EPS	Q4 FY2025	$2.02 to $2.12	$2.08	in-line with high end of guide	Beat
Adjusted Diluted EPS Growth	Q4 FY2025	+12% to +17% YoY	actual growth +14%	+1 to +2 pts above midpoint	Beat
Operating Income Margin	FY 2025	18%	17.9%	-0.1 pts (immaterial miss)	Beat

New guidance

Metric	Period	Guide	YoY
Adjusted Diluted EPS	Q1 FY2026	$1.67 to $1.73	+11% to +15%
Adjusted Diluted EPS Growth	Q1 FY2026	+11% to +15%	—
Adjusted Diluted EPS	FY 2026	$8.43 to $8.63	+12% to +15%
Adjusted Diluted EPS Growth	FY 2026	+12% to +15%	—
Reported Sales Growth	FY 2026	+7% to +9%	—
Organic Sales Growth	FY 2026	+3% to +4%	—
Operating Income Margin Expansion	FY 2026	+100 to +150 basis points	—
Adjusted Operating Income Growth	FY 2026	+14% to +16%	—

Reaffirmed unchanged this quarter: Adjusted Diluted EPS ($7.53)

Segment KPIs

Q4 FY2025

Segment	Q4 FY2025	YoY
Global Water	$2.124B	+4.0%
Global Institutional & Specialty	$1.548B	+4.0%
Global Pest Elimination	$0.317B	+8.0%
Global Life Sciences	$0.207B	+10.0%
Global High-Tech Growth (Light & Heavy segment)	Double-digit growth	—
Food & Beverage Sales Growth	Accelerating	—
Pest Elimination Organic Operating Income Growth	46%	—
Life Sciences Organic Sales Growth	7%	—

Other KPIs

Q4 FY2025

Segment	Q4 FY2025	YoY
Ecolab Digital Sales	$0.099B	+24.0%
Organic Sales Growth	3%	—
Organic Operating Income Growth	12%	—
Organic Operating Income Margin	18.5%	—
Share Repurchases	1.5 million shares	—

Management tone

Q1 FY2025 (anchor unavailable) → Q2 FY2025: 85% of the portfolio growing 4% → Q3 FY2025: "structural growth wave" reshaping the company → Q4 FY2025: "The best of Ecolab is yet to come"

OneEcolab savings target raised for the second time in twelve months — the cost program is compounding faster than management's own forecasts. Last quarter, OneEcolab was a quietly executing $225M-by-2027 program (already once-raised from $140M). This quarter, management raised it again to $325M, with $120M booked through end-2025 and $200M scheduled evenly across 2026–2027. From the call: "our initial OneEcoLab rollout exceeded expectations, allowing us to increase our savings target from $140 million to $225 million...And today, we're increasing our savings target again to $325 million." Two upward revisions in a single fiscal year against a multi-year target is a different signal than steady-state operational execution — it implies the SG&A leverage component of the FY2026 margin bridge is over-secured.

High-tech moved from rhetorical "growth wave" to sized business with secured customer wins. In Q3 FY2025 the CEO twice escalated high-tech without quantification, drawing a watch-list flag. This quarter management gave the number: ~$1B of revenue growing strong double digits, with Ovivo "off to a strong start in 2026, as we have already secured several new fabs where our leading ultra-pure water technologies will be deployed." The framing of Ecolab as "uniquely positioned in all these markets to help enable the AI build-out" — paired with the 17M-people-water-per-fab statistic and the 5%-to-80% water-recycling opportunity in semis — repositions Ecolab from a defensive industrial compounder to AI-infrastructure adjacent. That is a different multiple conversation.

Volume recovery has a specific date. Q2 FY2025 framed volume drag as a portfolio composition issue (85% fine, 15% cyclical); Q3 FY2025 said paper was "bottoming." Q4 FY2025 commits: "we expect volume growth to get back to 1% as we exit the first quarter, with growth accelerating further as the year progresses," and "the distributor impact to largely normalize in the first quarter of 2026." The cyclical drag and the distributor headwind both clear by Q1 FY2026 exit — making the FY2026 organic acceleration to +3–4% structurally easier to underwrite than at any point in 2025.

Pricing has moved off the marquee. After three quarters where pricing was the lead variable (3% target, surcharge mechanics, value-price acceleration), Q4 FY2025 framing is matter-of-fact: "we remain very confident in delivering 2% to 3% pricing this year." The absence of urgency suggests pricing has migrated from execution lever to baseline assumption — consistent with Q3 FY2025's note that inflation might offset some of the spread in 2026.

Recurring themes management leaned on this quarter:

Total Value Delivered (TVD) as formal customer outcome frameworkAI-driven growth across fabs, power, and data centersOneEcolab scaling driving 2-3% value pricing powerDigital transformation accelerating (25% of innovation pipeline)Life sciences targeting 30% long-term operating marginsPest elimination smart device expansion (targeting 1M devices in field)

Risks management surfaced:

Basic industries and paper sector performance remains headwindNon-cash amortization headwind from Avivo acquisitionLife sciences capacity constraints removing mid-2026 (implies prior supply risk)Minnesota geopolitical instability mentioned (though framed as corporate stewardship)

Q&A highlights

Manav Patniak · Barclays

Size and growth trajectory of global high-tech business (water, semis, data centers) post-Avivo acquisition, including opportunities and roadblocks to growth ambitions.

Global high-tech is a ~$1B business growing at strong double digits with very high margins. Avivo acquisition addresses circular water solutions for semiconductor fabs (which require water equivalent to 17M people per fab). Data centers shifting from air-cooled to liquid-cooled systems, moving toward water-based cooling. Management sees significant whitespace in these markets driven by AI infrastructure demands.

Global high-tech: ~$1 billion business, growing strong double digitsBy 2030: incremental power need equivalent to India's total electrical consumption; incremental freshwater need equivalent to entire US usageOne fab requires water equivalent to 17 million peopleSemiconductor manufacturing water purity: 1,000x more pure than blood injection water

Chris Parkinson · Wolf Research

Performance divergence within global water business (light vs heavy, mining, F&B inflation, paper drag); expectations for water segment growth trajectory to 3.5-4.5% range in 2026.

Water is 50% of company. Excluding paper and basic (cyclical downturns), water grew 5% in Q4. F&B growth accelerated to 5% (in flat end-market industry) through North America hygiene-water integration rollout globally. Global high-tech growing double digits. Paper and basic cyclical headwinds expected to normalize. Water margins at second-highest level in 5 years; targeting 20%+ margins going forward.

Water organic growth Q4: 2% reported, 5% excluding paper/basicF&B organic growth: 5% (rolling out globally beyond North America)Global high-tech: ~$1B, strong double-digit growthWater segment margin: second highest in last 5 years; target: 20%+ by 2027

Ashish Savajra · RBC Capital Markets

Drivers of 100-150 bps margin expansion target; incremental detail on 2026 savings and pricing contribution.

100-150 bps margin expansion anchored on: (1) gross margin expansion of 75-100 bps annually through value-based pricing, business mix shift, and innovation; (2) SG&A leverage of 25-50 bps through sales productivity (30% over 5 years) and OneEcoLab savings. OneEcoLab raised to $325M target (from $225M); ~$120M realized through end-2025, remaining $200M split evenly over 2026-2027.

OneEcoLab savings target raised to $325 millionOneEcoLab realized by end-2025: ~$120 millionOneEcoLab remaining: $200 million over 2026-2027Sales productivity improvement over 5 years: 30%

John McNulty · BMO Capital Markets

Explanation for differential incremental margins across segments (PEST showing explosive incremental margins vs. life sciences showing weak incremental growth); drivers and forward expectations.

PEST Q4 benefited from favorable year-over-year comp (spike in accidents in prior year created lower base). Life sciences grew 7% OI in Q4 (as expected), with underlying margins better than reported; investments in business and year-over-year comp comparison (sales accelerated mid-year, earning performance bonus) masked margin. Expected OI double-digit growth in 2026 for life sciences. Margins target: life sciences 20%+ by 2027 (currently north of 18%).

PEST OI margins: north of 20%PEST top-line growth: 7%Life sciences target OI margin range: mid-teens (management targeting)Life sciences full-year OI growth: 30%

Seth Webber · BNP Paribas

Detail on new business wins mentioned in prepared remarks; are these conquests from competitors or new companies/suppliers adding to base?

New business is #1 company focus with 'we're all in sales' mantra. Priority hierarchy: (1) top 35 customers (top 20 largest + emerging 15) with $3.5B gross potential; growing 2 percentage points faster than company; (2) large local customers globally; (3) individual customers. Global blitz 2 weeks prior drove 30% growth in new business vs. prior year same week. Focus on share-of-wallet expansion with existing customers through end-to-end solutions.

Top 35 customers gross potential: $3.5 billionTop 35 customer growth rate: 2+ percentage points above company averageGlobal blitz new business growth: 30% vs. prior year same weekCustomer retention: low to mid-90s (stable)

Answers to last quarter's watch list

FY2025 EPS landing within $7.48–$7.58. Resolved. FY2025 adjusted EPS came in at exactly $7.53, the midpoint. Q4 FY2025 EPS of $2.08 landed in the upper half of the $2.02–$2.12 guide — the range was navigated cleanly with no late-year scramble. Status: Resolved positively

Pricing sustainability past 3% as competitor surcharges age. Continue monitoring. Management's FY2026 commitment is "2% to 3% pricing" — confident, but the +3% achieved in Q3 FY2025 is no longer the explicit forward target. Total Q4 FY2025 pricing was not separately disclosed in the press release at the same granularity as prior quarters, and inflation remains a flagged 2026 headwind. The pricing-minus-cost spread thesis is intact but no longer expanding. Status: Continue monitoring

Paper segment inflection within 1–3 quarters. Continue monitoring. Management did not give an explicit paper-growth-rate update in the press release; the reference was to "basic industries and paper sector performance remains a headwind" and a broader expectation that "distributor impact to largely normalize in the first quarter of 2026." Volume returning to +1% by Q1 FY2026 exit implies cyclical drag fading but doesn't confirm paper-specific inflection. Status: Continue monitoring

High-tech segment disclosure quantification. Resolved. Management disclosed global high-tech as a ~$1B business growing strong double digits with high margins, plus quantified the Ovivo opportunity (new fabs already secured, fab water consumption math, recycling-rate gap). The number the Q3 FY2025 watch list demanded is now public. Status: Resolved positively

Operating margin Q4 FY2025 trajectory toward 18% FY target. Resolved. Q4 FY2025 organic OI margin held at 18.5% (+140bps YoY), and FY2025 came in at 17.9% — 10bps below 18% within rounding tolerance. The FY2026 +100–150bps expansion guide to ~18.9–19.3% keeps the 20%-by-2027 path live. Status: Resolved positively

What to watch into next quarter

Q1 FY2026 volume hitting +1% on exit. Management committed explicitly. If Q1 FY2026 volume doesn't clear +1% by quarter-end, the FY2026 +3–4% organic guide becomes back-half-loaded and dependent on the Q3/Q4 FY2026 distributor compare normalization holding.

Ovivo Electronics contribution disclosure. Reported +7–9% growth includes Ovivo; organic is +3–4%. Watch whether management discloses the discrete Ovivo contribution and whether the secured-fab wins translate into a quantified 2026 revenue number — without this, the AI-infrastructure narrative remains rhetorical at the segment level.

OneEcolab cadence through 2026. $100M of incremental savings needs to land in 2026 (half of the remaining $200M). Watch whether the H1 FY2026 run-rate is consistent with the even split, or whether the program is again ahead of schedule — a third upward revision would be the cleanest bull signal.

Operating margin landing in the 18.9–19.3% FY2026 band. The midpoint requires ~120bps expansion off FY2025's 17.9%. Watch Q1 FY2026 organic OI margin — if it doesn't clear 18.5% (Q4 FY2025's level), the back-half lift to land in-band becomes harder.

Water segment ex-paper growth holding at +5%. The "85% growing 5%" framing now needs to survive into 2026 as the paper compare eases. If ex-paper water growth decelerates below +5% as the cyclical tailwind kicks in, the underlying growth thesis weakens, not strengthens.

Sources

Ecolab Q4 FY2025 earnings press release, filed February 10, 2026 — https://www.sec.gov/Archives/edgar/data/31462/000110465926012358/ecl-20260210xex99d1.htm
Ecolab Q4 FY2025 management commentary as quoted within the press release (OneEcolab savings target raised to $325M, Ovivo fab wins, high-tech ~$1B disclosure, Q1 FY2026 volume +1% exit commitment, FY2026 margin bridge)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.